215 related articles for article (PubMed ID: 32338281)
21. Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑κB signaling pathway.
Jiang T; Li H; Jiang R; Li H; Hou P; Chen Y; Bai J; Song J
Oncol Rep; 2018 Sep; 40(3):1533-1544. PubMed ID: 30015978
[TBL] [Abstract][Full Text] [Related]
22. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
23. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.
Zhu Y; Zhang X; Qi M; Zhang Y; Ding F
J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290
[TBL] [Abstract][Full Text] [Related]
24. Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer.
Chaudhary N; Choudhary BS; Shah SG; Khapare N; Dwivedi N; Gaikwad A; Joshi N; Raichanna J; Basu S; Gurjar M; P K S; Saklani A; Gera P; Ramadwar M; Patil P; Thorat R; Gota V; Dhar SK; Gupta S; Das M; Dalal SN
Int J Cancer; 2021 Oct; 149(7):1495-1511. PubMed ID: 34146401
[TBL] [Abstract][Full Text] [Related]
25. Expression of TUSC3 and its prognostic significance in colorectal cancer.
Zhu YF; Dong M
Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
[TBL] [Abstract][Full Text] [Related]
26. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
[TBL] [Abstract][Full Text] [Related]
27. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
Pothuraju R; Rachagani S; Krishn SR; Chaudhary S; Nimmakayala RK; Siddiqui JA; Ganguly K; Lakshmanan I; Cox JL; Mallya K; Kaur S; Batra SK
Mol Cancer; 2020 Feb; 19(1):37. PubMed ID: 32098629
[TBL] [Abstract][Full Text] [Related]
28. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
[TBL] [Abstract][Full Text] [Related]
29. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
[TBL] [Abstract][Full Text] [Related]
30. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
31. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-κB pathway to promote metastasis.
Yuan Z; Hu H; Zhu Y; Zhang W; Fang Q; Qiao T; Ma T; Wang M; Huang R; Tang Q; Gao F; Zou C; Gao X; Wang G; Wang X
Cell Death Dis; 2021 May; 12(6):543. PubMed ID: 34035230
[TBL] [Abstract][Full Text] [Related]
33. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
[TBL] [Abstract][Full Text] [Related]
34. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma.
Liu M; Xiao Y; Tang W; Li J; Hong L; Dai W; Zhang W; Peng Y; Wu X; Wang J; Chen Y; Bai Y; Lin J; Yang Q; Wang Y; Lin Z; Liu S; Xiong J; Wang J; Xiang L
Cancer Med; 2020 Jun; 9(11):3932-3943. PubMed ID: 32281284
[TBL] [Abstract][Full Text] [Related]
35. CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer.
Wang B; Zheng J; Chen Q; Wu C; Li Y; Yu XY; Liu B; Liang C; Liu SB; Ding H; Wang S; Xue T; Song D; Lei Z; Amin HM; Song YH; Zhou J
Carcinogenesis; 2020 Jul; 41(6):841-849. PubMed ID: 31560739
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
37. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
38. Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure.
Francipane MG; Bulanin D; Lagasse E
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013771
[TBL] [Abstract][Full Text] [Related]
39. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells.
Feng S; Zhai J; Lu D; Lin J; Dong X; Liu X; Wu H; Roden AC; Brandi G; Tavolari S; Bille A; Cai K
Exp Cell Res; 2018 Dec; 373(1-2):44-56. PubMed ID: 30098333
[TBL] [Abstract][Full Text] [Related]
40. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
Qian F; Xiao J; Gai L; Zhu J
Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
